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ABSTRACT
The metal complexes of nine 2-substituted-lH-benzimidazoles (l-IX) with Ni(II), Pd(II), Cu(lI),
Ag(I), Zn(II) salts were synthesized. The compounds were characterized by melting point, analytical data, IR
spectroscopy and magnetic susceptibility. The antimicrobial activity of the compounds was determined by
the disk diffusion method in Mueller-Hinton Agar on Staphylococcus aureus 4TCC 6538, Staphylococcus
epidermidis 4TCC 12228, Escherichia coli 4TCC 8739, Klebsiella pneumoniae 4TCC 4352, Pseudomonas
aeruginosa 4TCC 1539, Salmonella typhi, Shigella flexneri, Proteus mirabilis, Candida albicans ,4TCC
10231. Cu(II)and Ag(1)complexes of II, Ill and IV showed considerable activity against S. aureus, S.
epidermidis, Ps. aeruginosa, S. typhi, Sh. flexneri and C. albicans microorganisms, the ligands themselves
having no effect.
INTRODUCTION
2-Substituted-lH-benzimidazoles have been associated with various types of biological effects such
as analgesic, antelmintic, antispasmodic, antifungal, antiviral and antiulcer activities[I-7]. In spite of the fact
that there are innumerable studies in this matter, the investigation concerned with biological activities of
metal complexes of 2-substituted-1H-benzimidazoles has been limited. Srivastava investigated metal chelates
of 2-(2’-hydroxybenzylidene)-aminobenzimidazole and compared the antifungal activity of the ligand with its
metal chelates[8]. In another study, it has been observed that the metal complexes were more fungitoxic than
corresponding ligand[9].
Nine 2-substituted-lH-benzimidazole derivatives (I-IX) (Figures and 2) and their 74 complexes
formed by reactions with NiCI2, PdCI2, Pd(NO3)2, CuCl2, Cu(CH3COO)2, Cu(CIO4)2, AgNO3, ZnCI2, ZnSO4
have been isolated in pure form for first time and characterized by using analytical data and IR spectroscopy.
The compounds i-IV, VIII and IX have variously biological activities, which are antinematodic[10],
fungicide[ 11], antelmintic[ 12], sedative[ 13] and antipoliovirus[ 14] for I, antifungal[ 15],
antinematodic[10,16], antelmintic[17], tuberculostatic[18] and antiinflammatory[19] for If, anti-
inflammatory[20] for 111, antifungal[15], nematocide[21], tuberculostatic[ 18] and antelmintic[17,22] for IV,
antipoliovirus[23] and antifungal[24] for VIII. The compound IX decreased the yield of intracellular
virus[25]. However, no biological potential of V, VI and VII was found until now.
In this research, the microbiological activity of the complexes were examined and compared with
that of the ligands by means of the disk diffusion method.
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Table 1" Analytical data and some physical properties of the metal complexes, exhibiting some
antimicrobial activity’, of I-IV, VI and VIII.
Mp Yield Elemental Analysis
Compound Color C (%) Found (Calculated) efr Solubility
%C %H %N
% M %C!
C3H0N_O cls. 243 75 74.33 4.81 13.39 EtOH
(74.28) (4.76) (13.33) DMSO,AcH
Ag[I]2NO3 light 232 70 51.67 3.50 9.68 29.07 0 DMSO
C26H2oAN505 .pink (52.88) (3.39) (9.49) (28.39) AcH
II cls. 218 40 73.96 4.78 21.38 EtOH
73 84)(4.6 )(21 54) DMSO,AcH C12H9N3
Ag[II]NO3 Light 70 40.46 2.45 14.81 30.11 0 DMSO
C2HgAgN403 brown >350 (39.45) (2.46)(15.34) (29.57) AcH
Cu[1112C!2 Green 330 70 54.82 3.38 15.95 12.46 21.20 1.7 DMSO
C24H,8CI2CuN6 (54.91) (3.43) (16.01) (12.11) (21.55) 2 AcH
Cu[ll]2(CIO4)z blue- 205 60 44.21 2.85 12.85 8.88 1.5 DMSO
C24H,bCI,_CuN608 green (44.14) (2.76)(12.87)(9.74) (10.88) 0
Ill cls. 222 35 74.67 5.29 20.04 0 EtOH
C,3H,,N3 (74.64) (5.26)(20.09) DMSO
Ag[III]NO3 Light 243’ 70 41.09 2.25 13.79 28.86 0 DMSO
C,3H,,AgN403 pink (41.16) (2.90).(14777) (28.47) AcH
Cu[Ill]CI2 dark 278 70 45.43 3.26 11.82 19.10 20.16 1.6 DMSO
C,3H,CIo_CuN3 ellow (45.41) (3.20)(12.22)(18.49)(20.67) 8
Cu[l||]2Cl2 yellow 285 65 56.44 3.95 15.08 11.77 12.19 1.7 DMSO
C26HzzCIzCuN6 (56.47) (3.98)(15.20)(11.50)(12.85) 5 EtOH
Cu[lIl]z(AcO),_ light 206 70 59.10 4.42 13.61 9.71 1.7 DMSO
C3oHzbCHN604 green (60.05) (4.67) (14.01) (10.60) AcH
Cu[11112(CIO4)_, light 262 65 45.52 3.24 12.05 9.93 1.7 DMSOI
C26HzzCIzCuN608 brown (45.85) (3.23)(12.34)(9734) (10.43) 4 EtOH
Ag[IV]NO3 cls. 301 75 39.28 2.49 14.92 29.75 0 DMSO
C,2HgAgN403 (39.45) (2.46) (15.34) (29.56) AcH
Cu[V|]Cl2 olive 315 60 48.76 3.11 14.09 15.63 17.76 1.3 DMSO
CI6HzCI,_CuN4 green (48.66) (3.04)(14.19)(16.10)(17.99) 7 AcH
Cu[VIII](CIO4)2 blue 216 75 34.37 2.62 10.45 11.72 1.0 DMSO, AcH
C,6H,3ClzCuN40,o (34.52) t2.53)(10.06)l11.414) t12.74) 9 water, EtOH
M.p. melting point. ILteff: magnetic moment; measured in DMSO, f2cm-mo1-1, at 25+1C. cls.: colorless.
MATERIALS AND METHODS
Preparation of the ligands
The ligands I-IV, were prepared by modifying slightly the literature method[l] and V-IX according
to the Phillips method[26]. Only ligand VI was obtained by using the melting process [27].
Aldehydes used to synthesize ligands I-IV and the yields obtained are: salicylaldehyde, 85% (1);
pyridine-2-carboxaldehyde, 37% (II); 6-methyl-pyridine-2-carboxaldehyde, 35% (III); pyridine-3-
carboxaldehyde, 55% (IV), respectively.
The dicarboxylic acids used and the yields obtained are: V, succinic acid, 78%; VI, maleic acid,
20%; VII, glutaric acid, 77%; VIII, tartaric acid, 75%; IX, mucic acid, 62%, respectively.
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Preparation of metal complexes in ethanol/water
A 5 mL aqueous solution of 0.04 M metal salts (0.2 mmole; e.g. 50 mg NiC12.6H20) and 0.4
mmole ligand (e.g. 80 mg II) in 25 mL of ethanol in a reaction tube was stirred vigorously. The solution
mixture was refluxed with stirring for about 4 hours. The metal complexes with AgNO3 were obtained for
one hour at 50+5C. The mixture was then allowed to stand at room temperature overnight to give a solid
product. This was then filtered, washed with water and ethanol, dried under vacuo over anhydrous CaCI2.
Compositions and purity of all the ligands and metal complexes were checked by using
microanalysis, IR, TLC and melting points.
Table 2: Some selected IR bands of the metal complexes showed antimicrobial activity,
of I-IV, Vl and VIII. (cm" in KBr disc)a
Compound v(NH) v(C=N)m v(C=N)p i(NH) Anion
Ligand 3230 1600 1538
Ag[I]2NO3
Ligand II
Cu[II]zCI2
Cu[II]2(CIO4)2
Ag[II]NO3
Ligand III
Cu[III]CI2
Cu[III]2C12
Cu[lll](Ac)
Cu[III]2(CIO4)2
Ag[lll]NO3
Ligand IV
Ag[IV]NO3
Ligand VI
Cu[VI]CIz
Ligand VIII
3246
H-bond.
3423
3438
3431
H-bond.
3169
3107
3423
3431
3192
H-bond.
3231
H-bond.
3431
H-bond.
1608
1592
1615
1638
1638
1600
1615
1615
1608
1615
1600
1600
1631
1592
1577
1592
Cu[VIII](CIO4)2 3223 1608
v(C=N)m and v( C=N)py bands medium, the vl
1569
1608
1608
1600
1577
1584
1592
1577
1584
1577
1584
1600
1538
1546
1546
1577
1569
1538
1546
1546
1546
1546
1538
1546
1546
1546
1523
1538
1531
1384
1100
1384
1415
1092
1384
1384
-1100
NH) and v(OH) broad, v(C-O)
bands sharp and 5(NH) bands weak.
Frequencies of v(C=C)al, and v(C=C)ar are 1623 and 1631, respectively. The
streching frequencies of phenolic C-O are between 1269-1284 cm
-1 and of alcoholic
C-O groups between 1061-1160 cm-. v(OH) bands appear in 3320-3400 cm
-! range.
Antimicrobial activity of the compounds
The disk diffusion method was used for determining the antimicrobial activity. The antibacterial
activity against Staphylococcus aureus ATCC 6538, S. epidermidis ATCC 12228, Escherichia coli ATCC
8739, Klebsiella pneumoniae ATCC 4352, Pseudomonas aeruginosa ATCC 1539, Salmonella typhL
Shigella flexneri and the antifungal activity against Candida albicans ATCC 10231 were investigated.
Mueller-Hinton agar (Difco, Detroit, USA) was melted at 100C and then cooled to 56C, was poured into
plates of 9 cm diameter in quantities of 20 mL, and let on a flat surface to solidify and the surface of the
medium was dried at 37C. Then, cultures of each bacteria and yeast strain, after being kept in Mueller-
Hinton broth (Difco) at 37C for 18-24 hours and diluted with Mueller-Hinton broth to 10 cfu/mL, were
pipetted into the Mueller-Hinton agar plates prepared as described above. The surface of the medium was
allowed to dry. The 10 mg/mL (in DMSO, E. Merck)compound imPoregnated disks were applied to the
surface of inoculated plates. The plates were placed in an incubator at 3 7 C. After 18-24 hours of incubation,
the plates were examined and the compounds which were found effective against the strains were selected in
order to determine the minimum inhibitory concentrations.
Determination ofMIC The minimum inhibitory concentrations were determined by the microbroth
dilution technique using Mueller-Hinton broth. Serial two-fold dilutions ranging from 5000 to 4.8 mcg/mL
were prepared in Mueller-Hinton broth. The inoculum was prepared with a 4-6 hours broth culture of each
strain adjusted to a turbidity’ equivalen to 0.5 McFarland standard, diluted in Mueller-Hinton broth to give a
f’mal concentration of 5x10 cfu/L in the test tray. The trays were covered and placed in plastic bags to
prevent drying; incubation was at 37C for 18-20 hours. The MIC was defined as the lowest concentration of
compound giving complete inhibition of visible growth. MIC values of compounds are given Table 3.
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Table 3" MIC values (mcg/mL of the compounds
Microorganism
Compound
Ag[I]2NO3
II
Ag[II]NO3
Cu[1112C12
Cu[1112(CIO4)2
III
Ag[III]NO3
Cu[III]CI2
Cu[III]2C12
Cu[lll]2(Ac)_
Cu[III]2(CIO4)2
Ag[IV]NO3
Cu[VI]CI2
Cu[VII|](CIO4)2
AgNO3
A B C D E F G
39 39 39 39 19.5 39 39
9.8 19.5 19.5 19.5 19.5 19.5 19.5
78 39
78 78 78
9.8 9.8 9.8 39 9.8 9.8 9.8
156 78
156 78
250 125
156 78
19.5 19.5 19.5 19.5 19.5 19.5 19.5
39
9.8
9.8 4.9 4.9 4.9 4.9
39
250
19.5
H
250
9.8
250
156
19.5
": A, Staphylococcus aureus ATCC 6538; B, Staphylococcus epidermidis ATCC 12228,"
C, Escherichia coli ATCC 8739; D, Klebsiella pneumoniae ATCC 4352; E, Pseudomonas
aeruginosa ATCC 1539; F, Salmonella typhi," G, Shigella flexneri; H, Candida albicans
ATCC 10231.
-’very low MIC value.
RESULTS AND DISCUSSIONS
Composition of the compounds
The interaction of the ligands (I-IX) with the metal salts in a 1:2 molar ratio in ethanol yielded
stable solid complexes corresponding to the general formulas [M(L)A,,] and [M(L),A,,] (where A AcO-,
C l-, CIO4-and NO3-. /7 equals in the all of Ag(I) complexes, and 2 in the other complexes). All the
complexes are very poorly soluble in common organic solvents such as dichloromethane and polar solvents
such as EtOH and MeOH, but are moderate soluble in donor solvents, such as dimethylsulfoxide (DMSO).
The analytical results and some physical properties of these compounds are shown in Table 1.
Some selected IR bands of the complexes are shown in Table 2. According to literature, the
coordinations occur through the C=N nitrogen atom of imidazole in all the complexes[28]. The v(C=N)
bands of imidazole and the v(C=N) bands of pyridine of the ligands II, III and IV can be clearly seen in the
IR spectra. Imidazole v(C=N) band in all the metal complexes and both v(C=N) bands in the metal
complexes of II-IV are shifted to higher frequencies compared with those of the free ligands by 5-40 cm-.
Similarly, the v(C-O) band frequencies of phenol and alcohol groups in the ligands increase on
complexation. In addition to this, the characteristic acetate, nitrate and perchlorate bands confirm the
suggested tentative formula of the complexes.
Antimicrobiai activity of the ligands and their metal complexes
The antimicrobial activity (MIC, tg/mL) of the compounds are shown in Table 3. From Table 3,
the complexes of II! with Cu(ll)and Ag(I) have various antimicrobial activities. Cu(II) salts and II and III
ligands which are not effective alone to two (S. azreus and S. epideridis) of the nine bacteria, however, they
show some effect in their Cu(II)-complex form. This effect can be logically explained by the fact that the
benzimidazole derivatives must be activated by Cu(II) ions in some way (maybe synergetic activity).
However, we think that the activity was revealed as a result of the independent characteristic of the metal
complexes. We presume that this effect is due to the formation of an "enzyme-Cu(II)-benzimidazole" mixed
complex, by the bonding of metal complexes through the metal atom to the microorganism’s cell enzymes.
The ternary complexes, composed of enzyme, metal ion and organic ligand, may be likely proposed
considering the results in the some biological studies[29-32]. The benzimidazole derivative, which is the
organic portion of this complex structure, is responsible for the ineffectiveness of the said Cu(lI) complexes to
the other bacteria except S. aureus and S. epidermidis. The expected activity, in the form of Cu(II)
complexes, will be obtained by appropriate benzimidazole derivatives, even though they may not be active
alone by themselves.
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